Skip to Content

MD Anderson Events

Protein Methyltransferase Inhibitors as Personalized Cancer Therapeutics

Protein Methyltransferase Inhibitors as Personalized Cancer Therapeutics

Seminar hosted by the Institute for Applied Cancer Research

Date: 9/4/13, 9am to 10:30am
Time: 9/4/13, 9am to 10:30am
Location: South Campus - 4SCR1.1110
Format: Seminar/Conference
CME: 0
Facilitator: Carlo Toniatti
Speaker: Robert Copeland, Ph.D.
Speaker Bio: Chief Scientific Officer Epizyme, Inc. Cambridge, MA
Contact: Shannon Hurst - 7928543 - shurst@mdanderson.org